Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hemlibra
Pharma
UPDATED: Roche Q1 earnings see hits and misses across key products
The surging Swiss franc caused Roche's Q1 sales to fall slightly short of Wall Street expectations with a “mix of beats and misses” across key drugs.
Angus Liu
Apr 24, 2026 1:55pm
Genentech shifts Hemlibra marketing focus to patient stories
Apr 20, 2026 9:30am
Roche overcomes drug-specific struggles, currency woes in Q3
Oct 23, 2025 12:15pm
Genentech honors hemophilia A caregivers in Hemlibra short film
May 14, 2025 12:48pm
BioMarin's hemophilia gene therapy needs 3 stars to align: CEO
Feb 23, 2024 10:15am
JPM24: Roche touts its rebound in hematology, led by Hemlibra
Jan 9, 2024 4:26pm
